{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:53:40Z","timestamp":1790704420304,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1007\/s11908-001-0094-4","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T13:01:23Z","timestamp":1180098083000},"page":"553-560","source":"Crossref","is-referenced-by-count":9,"title":["Mitochondrial toxicity associated with nucleoside reverse transcriptase inhibitor therapy"],"prefix":"10.1007","volume":"3","author":[{"given":"Cecilia M.","family":"Shikuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Shiramizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"94_CR1","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1126\/science.283.5407.1482","volume":"283","author":"DC Wallace","year":"1999","unstructured":"Wallace DC: Mitochondrial diseases in man and mouse. Science 1999, 283:1482\u20131487. ellent general review of mitochondrial diseases.","journal-title":"Science"},{"key":"94_CR2","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/00002030-199814000-00004","volume":"12","author":"K Brinkman","year":"1998","unstructured":"Brinkman K, ter Hofstede HJM, Burger DM, et al.: Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 1998, 12:1735\u20131744. Good review of NRTI-mediated mitochondrial toxicity.","journal-title":"AIDS"},{"key":"94_CR3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nm0595-417","volume":"1","author":"W Lewis","year":"1995","unstructured":"Lewis W, Dalakas MC: Mitochondrial toxicity of antiviral drugs. Nat Med 1995, 1:417\u2013422.","journal-title":"Nat Med"},{"key":"94_CR4","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/2261209a0","volume":"226","author":"D Baltimore","year":"1970","unstructured":"Baltimore D: Viral RNA-dependent DNA polymerase: RNAdependent DNA polymerase in virions of RNA tumour virses. Nature 1970, 226:1209\u20131211.","journal-title":"Nature"},{"key":"94_CR5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF01880662","volume":"16","author":"J Balzarini","year":"1994","unstructured":"Balzarini J: Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives. Pharm World Sci 1994, 16:113\u2013126.","journal-title":"Pharm World Sci"},{"key":"94_CR6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0149-2918(00)90004-3","volume":"22","author":"TN Kakuda","year":"2000","unstructured":"Kakuda TN: Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther 2000, 22:685\u2013708.","journal-title":"Clin Ther"},{"key":"94_CR7","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1172\/JCI116463","volume":"91","author":"WY Gao","year":"1993","unstructured":"Gao WY, Shirasaka T, Johns DG, et al.: Differential phosphorylation of azidothymidine, dideoxycytidine and dideoxyinosine in resting and activated peripheral blood mononuclear cells. J Clin Invest 1993, 91:2326\u20132333.","journal-title":"J Clin Invest"},{"key":"94_CR8","doi-asserted-by":"crossref","first-page":"12633","DOI":"10.1016\/S0021-9258(18)99923-0","volume":"2691","author":"WY Gao","year":"1994","unstructured":"Gao WY, Agbaria R, Driscoll JS, et al.: Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2\u20323\u2032-dideoxynucleoside analogs in resting and activated human cells. J Biol Chem 1994, 2691:12633\u201312638.","journal-title":"J Biol Chem"},{"key":"94_CR9","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1016\/S0021-9258(18)80156-9","volume":"264","author":"C-H Chen","year":"1989","unstructured":"Chen C-H, Cheng Y-C: Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2\u20323\u2032-dideoxycytidine. J Biol Chem 1989, 264:11934\u201311937.","journal-title":"J Biol Chem"},{"key":"94_CR10","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1128\/AAC.38.8.1824","volume":"38","author":"DJ Medina","year":"1994","unstructured":"Medina DJ, Tsai C-H, Hsiung GD, et al.: Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus didoxynucleosides. Antimicrob Agents Chemother 1994, 38:1824\u20131828.","journal-title":"Antimicrob Agents Chemother"},{"key":"94_CR11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1383-5718(97)00014-4","volume":"390","author":"RP Agarwal","year":"1997","unstructured":"Agarwal RP, Olivero OA: Genotoxicity and mitochondrial damage in human lymphocytic cells chronically exposed to 3\u2032-azido-2\u2032,3\u2032-dideoxythymidine. Mutat Res 1997, 390:223\u2013231.","journal-title":"Mutat Res"},{"key":"94_CR12","first-page":"625","volume":"39","author":"CH Chen","year":"1991","unstructured":"Chen CH, Vazquez PM, Cheng YC: Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Mol Pharmacol 1991, 39:625\u2013628.","journal-title":"Mol Pharmacol"},{"key":"94_CR13","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1073\/pnas.031430998","volume":"98","author":"V Dolce","year":"2001","unstructured":"Dolce V, Fiermonte G, Runswick MJ, et al.: The human mitochondrial deoxynucleotide carrier and its role in the toxicity of nucleoside antivirals. Proc Nalt Acad Sci U S A 2001, 98:2284\u20132288.","journal-title":"Proc Nalt Acad Sci U S A"},{"key":"94_CR14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0026-0495(97)90259-6","volume":"46","author":"PW Stacpoole","year":"1997","unstructured":"Stacpoole PW: Lactic acidosis and other mitochondrial disorders. Metabolism 1997, 46:306\u2013321.","journal-title":"Metabolism"},{"key":"94_CR15","unstructured":"Boxwell DE, Styrt BA: Lactic acidosis in patients receiving nucleoside reverse transcriptase inhibitors. Paper presented at 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco. September 26\u201329, 1999."},{"key":"94_CR16","unstructured":"Lonergan JT, Havlier D, Behling C, et al.: Hyperlactatemia in 20 patients receiving NRTI combination regimens. Paper presented at 7th Conference on Retroviruses and Opportunistic Infections. San Francisco. January 30\u2013February 2, 2000."},{"key":"94_CR17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2337\/diab.32.2.181","volume":"32","author":"RD Cohen","year":"1983","unstructured":"Cohen RD, Woods HF: Review: lactic acidosis revisited. Diabetes 1983, 32:181\u2013191.","journal-title":"Diabetes"},{"key":"94_CR18","doi-asserted-by":"crossref","unstructured":"Vrouenraets SME, Treskes M, Regez RM: Hyperlactatemia in HIV-infected patients: the role of NRTI treatment. Paper presented at 8th Conference on Retroviruses and Opportunistic Infections. Chicago. February 4\u20138, 2001.","DOI":"10.1177\/135965350200700402"},{"key":"94_CR19","unstructured":"Boubaker K, Sudre P, Flepp M, et al.: Hyperlactatemia and antiretroviral therapy in the Swiss HIV Cohort Study (SHCS). Paper presented at 7th Conference on Retroviruses and Opportunistic Infections. San Francisco. January 30\u2013February 2, 2000."},{"key":"94_CR20","first-page":"5","volume":"86","author":"BS Peters","year":"1993","unstructured":"Peters BS, Winer J, Landom DN: Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS. Am J Med 1993, 86:5\u201315.","journal-title":"Am J Med"},{"key":"94_CR21","first-page":"971","volume":"43","author":"DM Simpson","year":"1997","unstructured":"Simpson DM, Slasor P, Dafni U, et al.: Analysis of myopathy in a placebo-controlled zidovudine trial. Muscle Nerve 1997, 43:971\u2013976.","journal-title":"Muscle Nerve"},{"key":"94_CR22","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1097\/00002030-199818000-00011","volume":"12","author":"DM Simpson","year":"1998","unstructured":"Simpson DM, Katzenstein DA, Hughes MD, et al.: Neuromuscular function in HIV infection: analysis of a placebo-controlled combination antiretroviral trial. AIDS 1998, 12:2425\u20132432.","journal-title":"AIDS"},{"key":"94_CR23","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0140-6736(91)91294-5","volume":"337","author":"E Arnaudo","year":"1991","unstructured":"Arnaudo E, Dalakas M, Shanske S, et al.: Depletion of muscle mitochondrial DNA in AIDS patients with zidovudineinduced myopathy. The Lancet 1991, 337:508\u2013510.","journal-title":"The Lancet"},{"key":"94_CR24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/0003-4819-116-4-311","volume":"116","author":"A Herskowitz","year":"1992","unstructured":"Herskowitz A, Willoughby SB, Baughman KL: Cardiomyopathy associated with antiretroviral therapy in patients with HIV infection. Ann Intern Med 1992, 116:311\u2013313.","journal-title":"Ann Intern Med"},{"key":"94_CR25","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1056\/NEJM199210293271802","volume":"327","author":"SE Lipshultz","year":"1992","unstructured":"Lipshultz SE, Orav EJ, Sanders SP, et al.: Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine. N Engl J Med 1992, 327:1260\u20131265.","journal-title":"N Engl J Med"},{"key":"94_CR26","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM200009143431102","volume":"343","author":"SE Lipshultz","year":"2000","unstructured":"Lipshultz SE, Easley KA, Orav EJ, et al.: Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med 2000, 343:759\u2013766.","journal-title":"N Engl J Med"},{"key":"94_CR27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2165\/00003495-199346030-00010","volume":"46","author":"MI Wilde","year":"1993","unstructured":"Wilde MI, Langtry HD: Zidovudine: an update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1993, 46:515\u2013578.","journal-title":"Drugs"},{"key":"94_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajh.2830350102","volume":"35","author":"JD Lutton","year":"1990","unstructured":"Lutton JD, Mathew A, Levere RD, et al.: Role of heme metabolism in AZT-induced bone marrow toxicity. Am J Hematol 1990, 35:1\u20135.","journal-title":"Am J Hematol"},{"key":"94_CR29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0192-0561(93)90103-6","volume":"15","author":"VS Gallicchio","year":"1993","unstructured":"Gallicchio VS, Hughes NK, Tse KF: Comparison of dideoxynucleoside drugs (DDI and zidovudine) and induction of hematopoietic toxicity using normal human bone marrow cells in vitro. Int J Immunopharmacol 1993, 15:263\u2013268.","journal-title":"Int J Immunopharmacol"},{"issue":"Suppl 1","key":"94_CR30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0192-0561(91)90131-P","volume":"13","author":"MI Luster","year":"1991","unstructured":"Luster MI, Rosenthal GJ, Cao W, et al.: Experimental studies of the hematologic and immune system toxicity of nucleoside derivatives used against HIV infection. Int J Immunopharmacol 1991, 13(Suppl 1):99\u2013107.","journal-title":"Int J Immunopharmacol"},{"key":"94_CR31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1128\/AAC.38.5.924","volume":"38","author":"A Faraj","year":"1994","unstructured":"Faraj A, Fowler DA, Bridges EG, et al.: Effects of 2\u2032,3\u2032-dideoxynucleosides on proliferation and differentiation of human pluripotent progenitors in liquid culture and their effects on mitochondrial DNA synthesis. Antimicrob Agents Chemother 1994, 38:924\u2013930.","journal-title":"Antimicrob Agents Chemother"},{"key":"94_CR32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00042560-199510020-00009","volume":"10","author":"CJ Fichtenbaum","year":"1995","unstructured":"Fichtenbaum CJ, Clifford DB, Powderly WG: Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 10:169\u2013174.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"94_CR33","first-page":"153","volume":"9","author":"DM Simpson","year":"1995","unstructured":"Simpson DM, Tagliati M: Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 9:153\u2013161.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"94_CR34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2165\/00002018-199819060-00005","volume":"19","author":"GJ Moyle","year":"1998","unstructured":"Moyle GJ, Sadler M: Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management. Drug Saf 1998, 19:481\u2013494.","journal-title":"Drug Saf"},{"key":"94_CR35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00002030-200002180-00009","volume":"14","author":"RD Moore","year":"2000","unstructured":"Moore RD, Wong WM, Keruly JC, et al.: Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea. AIDS 2000, 14:273\u2013278.","journal-title":"AIDS"},{"key":"94_CR36","unstructured":"Brew B, Tisch S, Law M: Lactate concentrations distinguish between nucleoside neuropathy and HIV distal symmetrical sensory polyneuropathy. Paper presented at 8th Conference on Retroviruses and Opportunistic Infections. Chicago. February 4\u20138, 2001."},{"key":"94_CR37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0002-9343(99)00169-2","volume":"107","author":"T Dassopoulos","year":"1999","unstructured":"Dassopoulos T, Ehrenpreis ED: Acute pancreatitis in human immunodeficiency virus-infected patients: a review. Am J Med 1999, 107:78\u201384.","journal-title":"Am J Med"},{"key":"94_CR38","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00002030-200103300-00011","volume":"15","author":"RD Moore","year":"2001","unstructured":"Moore RD, Keruly JC, Chaisson RE: Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs. AIDS 2001, 15:617\u2013620.","journal-title":"AIDS"},{"key":"94_CR39","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1097\/00002030-200109070-00012","volume":"15","author":"A Foli","year":"2001","unstructured":"Foli A, Benvenuto F, Piccinini G, et al.: Direct analysis of mitochondrial toxicity of antiretroviral drugs. AIDS 2001, 15:1687\u20131694.","journal-title":"AIDS"},{"key":"94_CR40","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1023\/A:1010618627594","volume":"46","author":"G Lake-Bakaar","year":"2001","unstructured":"Lake-Bakaar G, Mazzoccoli V, Dickman K, et al.: Differential effects of nucleoside analogs on oxidative phosphorylation in human pancreatic cells. Dig Dis Sci 2001, 46:1853\u20131863.","journal-title":"Dig Dis Sci"},{"key":"94_CR41","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","volume":"354","author":"K Brinkman","year":"1999","unstructured":"Brinkman K, Smeitink J, Romijn J, et al.: Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet 1999, 354:1112\u20131115. Hypothesis of NRTI-mediated mitochondrial toxicity as an explanation for HAART-associated lipodystrophy.","journal-title":"Lancet"},{"key":"94_CR42","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1097\/00002030-199911120-00019","volume":"13","author":"T Kakuda","year":"1999","unstructured":"Kakuda T, Brundage RC, Anderson PL, et al.: Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy [letter]. AIDS 1999, 13:2311\u20132312.","journal-title":"AIDS"},{"key":"94_CR43","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1006877012241","volume":"174","author":"T Klopstock","year":"1994","unstructured":"Klopstock T, Naumann M, Seibel F, et al.: Mitochondrial DNA mutations in multiple symmetric lipomatosis. Mol Cell Biochem 1994, 174:271\u2013275.","journal-title":"Mol Cell Biochem"},{"key":"94_CR44","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/(SICI)1097-4598(199707)20:7<833::AID-MUS7>3.0.CO;2-8","volume":"20","author":"M Naumann","year":"1997","unstructured":"Naumann M, Kiefer R, Toyka KV, et al.: Mitochondrial dysfunction with myoclonus epilepsy and ragged-red fibers point mutation in nerve, muscle, and adipose tissue of a patient with multiple symmetric lipomatosis. Muscle Nerve 1997, 20:833\u2013839.","journal-title":"Muscle Nerve"},{"key":"94_CR45","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s004030050368","volume":"290","author":"P Becker-Wegerich","year":"1998","unstructured":"Becker-Wegerich P, Steuber M, Olbrisch R, et al.: Defects of mitochondrial respiratory chain in multiple symmetric lipomatosis. Arch Dermatol Res 1998, 290:652\u2013655.","journal-title":"Arch Dermatol Res"},{"key":"94_CR46","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00002030-199909100-00009","volume":"13","author":"T Saint-Marc","year":"1999","unstructured":"Saint-Marc T, Partisani M, Poizot-Martin I, et al.: A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy. AIDS 1999, 13:1659\u20131667.","journal-title":"AIDS"},{"key":"94_CR47","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/00002030-200007070-00002","volume":"14","author":"J Mallal","year":"2000","unstructured":"Mallal J, John M, Moor CB, et al.: Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS 2000, 14:1309\u20131316.","journal-title":"AIDS"},{"key":"94_CR48","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","volume":"15","author":"K Lichtenstein","year":"2001","unstructured":"Lichtenstein K, Ward D, Delaney K, et al.: Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS 2001, 15:1389\u20131398.","journal-title":"AIDS"},{"key":"94_CR49","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","volume":"14","author":"A Carr","year":"2000","unstructured":"Carr A, Miller J, Law M, Cooper DA: A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS 2000, 14:F25-F32.","journal-title":"AIDS"},{"issue":"Suppl 5","key":"94_CR50","first-page":"5","volume":"5","author":"UA Walker","year":"2000","unstructured":"Walker UA, Bickel M, L\u00fctke Volksbeck SI, et al.: Decrease of mitochondrial DNA content in adipose tissue of HIV-1 infected patients treated with NRTIs. Antiviral Ther 2000, 5(Suppl 5):5.","journal-title":"Antiviral Ther"},{"key":"94_CR51","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1097\/00002030-200109280-00009","volume":"15","author":"CM Shikuma","year":"2001","unstructured":"Shikuma CM, Hu N, Milne C, et al.: Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV infected individuals with peripheral lipoatrophy. AIDS 2001, 15:1801\u20131809.","journal-title":"AIDS"},{"key":"94_CR52","unstructured":"Mallal SA, Hammond EL, Martin A, et al.: Mitochondrial DNA depletion, assessed by real-time PCR-based quantitative assay, in subcutaneous fat of HIV-infected patients: evidence for a role in the etiology of fat wasting. Paper presented at 4th International Conference on Nutrition and HIV Infection\/2nd European Workshop on Lipodystrophy. Cannes, France. April 19\u201321, 2001."},{"key":"94_CR53","doi-asserted-by":"crossref","unstructured":"Mallal S, Nolan D, John M, et al.: Light and electron microscopy findings in subcutaneous fat in antiretroviral treated and HIV-infected patients. Paper presented at XIII International AIDS Conference. Durban, South Africa. July 9\u201314, 2000.","DOI":"10.1097\/00002030-200007070-00002"},{"key":"94_CR54","unstructured":"Blanche S, Rouzioux C, Mandelbrot L, et al.: Zidovudine-lamivudine for prevention of mother to child HIV-1 transmission. French National Study. Paper presented at 6th Conference on Retroviruses and Opportunistic Infections. Chicago. January 31\u2013February 4, 1999."},{"key":"94_CR55","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(99)07219-0","volume":"354","author":"S Blanche","year":"1999","unstructured":"Blanche S, Tardieu M, Rustin P, et al.: Persistent mitochondrial dysfunction and perinatal exposure to anti-retroviral nucleoside analogues. Lancet 1999, 354:1084\u20131089.","journal-title":"Lancet"},{"key":"94_CR56","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1749-6632.2000.tb05496.x","volume":"918","author":"M Gerschenson","year":"2000","unstructured":"Gerschenson M, Poirier MC: Fetal patas monkeys sustain mitochondrial toxicity as a result of in utero zidovudine exposure. Ann NY Acad Sci 2000, 918:269\u2013281.","journal-title":"Ann NY Acad Sci"},{"key":"94_CR57","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00126334-200006010-00003","volume":"24","author":"EL Ewings","year":"2000","unstructured":"Ewings EL, Gerschenson M, St Claire MC, et al.: Genotoxic and functional consequences of tran splacental zidovudine exposure in fetal monkey brain mitochondria. J Acquir Immune Defic Syndr 2000, 24:100\u2013105.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"94_CR58","unstructured":"Hanson C, Frederick M, McIntosh K: Evaluation of living uninfected children for mitochondrial defects: Women and Infants Transmission Study. Paper presented at 7th Conference on Retroviruses and Opportunistic Infections. San Francisco. January 30\u2013February 2, 2000."},{"key":"94_CR59","unstructured":"McIntosh K: Mitochondrial toxicity of perinatally administered zidovudine. Paper presented at 7th Conference on Retroviruses and Opportunistic Infections. San Francisco. January 30\u2013February 2, 2000."},{"key":"94_CR60","first-page":"5","volume":"86","author":"BS Peters","year":"1993","unstructured":"Peters BS, Winer J, Landon DN, et al.: Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS. Q J Med 1993, 86:5\u201315.","journal-title":"Q J Med"},{"key":"94_CR61","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1097\/00002030-199910220-00035","volume":"13","author":"T Saint-Marc","year":"1999","unstructured":"Saint-Marc T, Touraine JL: The effects of discontinuing stavudine therapy on clinical and metabolic abnormalities in patients suffering from lipodystrophy. AIDS 1999, 13:2188\u20132189.","journal-title":"AIDS"},{"key":"94_CR62","unstructured":"Brinkman K: Special lecture: current developments of mitochondrial toxicity, focusing on lactic acidosis and hyperlactatemia and treatment. Paper presented at 4th International Conference on Nutrition and HIV Infection\/2nd European Workshop on Lipodystrophy. Cannes, France. April 19\u201321, 2001."}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-001-0094-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-001-0094-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-001-0094-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T01:01:49Z","timestamp":1683853309000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-001-0094-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["94"],"URL":"https:\/\/doi.org\/10.1007\/s11908-001-0094-4","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}